Rockwell Medical Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.5% | +9.0% | -9.2% | +10.4% | +1.4% | +0.7% | -0.2% | +11.8% | +1.1% | -7.7% | -4.6% | +3.8% | +0.5% | +2.4% | +0.2% | -3.9% | -0.8% | +2.0% | -2.2% | +5.6% | -4.1% | +5.2% | +15.9% | +0.0% | +3.3% | +1.8% | -8.1% | +31.5% | -7.1% | +2.6% | +13.9% | +9.6% | -12.9% | -23.3% | -15.0% | -0.9% | +15.2% | -5.5% | +2.6% | – | |
| – | +1.5% | +7.3% | -4.0% | +15.4% | +18.5% | -7.1% | +26.9% | -22.3% | +6.6% | -7.2% | -3.0% | +9.3% | -6.8% | +2.5% | +1.8% | -0.5% | -1.0% | +2.0% | +2.2% | +6.0% | +7.6% | -3.7% | +0.2% | +5.8% | -5.3% | +0.6% | -0.1% | +26.5% | -10.9% | +2.0% | +8.5% | +3.7% | -4.7% | -24.5% | -14.5% | +0.6% | +6.0% | -0.2% | +0.7% | – | |
| – | +25.8% | +18.6% | -36.4% | -28.5% | -214.4% | – | -13,713.7% | – | -39.9% | -14.7% | -27.4% | -102.2% | – | +0.1% | -20.8% | -60.7% | +11.3% | +4.2% | -165.3% | – | – | – | – | -55.5% | +201.2% | +11.1% | -60.3% | +113.2% | +30.3% | +6.8% | +48.5% | +37.1% | -41.8% | -16.2% | -17.7% | -9.2% | +70.7% | -25.3% | +11.9% | – | |
| – | -4.8% | +1.2% | +37.9% | -22.1% | +63.0% | -21.6% | -6.4% | -48.2% | +235.2% | -81.6% | +494.9% | -50.1% | +32.6% | -6.8% | -11.3% | +8.0% | +9.4% | -5.2% | +33.6% | -49.5% | +13.8% | +12.7% | -40.9% | -49.4% | -66.7% | +78.2% | -39.9% | +195.8% | -66.0% | -89.3% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | +19.3% | +0.8% | +7.2% | -26.7% | +22.5% | -46.9% | +77.3% | +9.2% | +26.1% | -18.3% | -11.6% | -15.9% | +0.7% | +13.2% | -45.6% | +26.2% | +21.9% | -11.1% | -6.3% | +5.5% | +22.1% | -19.4% | +25.1% | -31.9% | +16.7% | -14.4% | +1.4% | -12.3% | -6.3% | +39.4% | -8.7% | +3.7% | -7.6% | +11.6% | -11.1% | +1.4% | +12.4% | +2.0% | -3.2% | – | |
| – | +14.5% | +0.9% | +12.3% | -25.8% | +31.2% | -15.9% | +7.8% | -3.9% | +52.3% | -7.4% | +8.7% | -25.7% | +7.4% | +7.7% | -29.3% | +8.5% | +20.2% | -10.3% | -0.3% | -12.1% | +256.6% | -75.3% | +6.6% | -28.0% | -4.0% | -6.5% | -0.8% | -1.3% | -13.3% | +28.4% | -8.0% | +6.6% | -3.6% | +6.1% | -12.5% | +0.1% | +10.9% | +2.4% | -1.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +275.9% | -126.8% | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | -91.3% | +467.8% | +0.0% | -100.0% | – | – | – | – | – | – | – | +410.8% | +27.8% | -11.4% | -1.5% | +0.3% | +4.5% | -3.4% | -8.2% | -10.2% | -1.9% | -7.8% | -11.8% | +2.1% | +4.1% | +169.6% | -61.1% | -46.2% | +30.2% | -4.3% | -4.2% | -0.4% | +3.3% | +0.4% | -1.4% | -0.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +385.1% | -145.4% | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | -410.7% | – | +1,199.3% | -99.9% | +5,200.0% | – | – | – | -9.5% | -0.6% | -18.3% | +80.2% | -93.1% | -1,251.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +385.1% | -145.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -617.1% | – | +123.2% | -97.0% | -1,019.7% | – | – | – | -392.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.